Premium
Placenta‐specific gene activation and inactivation using integrase‐defective lentiviral vectors with the Cre/ LoxP system
Author(s) -
Morioka Yuka,
Isotani Ayako,
Oshima Robert G.,
Okabe Masaru,
Ikawa Masahito
Publication year - 2009
Publication title -
genesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.093
H-Index - 110
eISSN - 1526-968X
pISSN - 1526-954X
DOI - 10.1002/dvg.20563
Subject(s) - cre recombinase , biology , cre lox recombination , transgene , gene targeting , viral vector , embryonic stem cell , microbiology and biotechnology , placentation , placenta , gene knockout , transduction (biophysics) , mutant , conditional gene knockout , gene , genetics , phenotype , genetically modified mouse , fetus , recombinant dna , pregnancy , biochemistry
Transgenic and knockout studies have advanced our understanding of the genetic control of embryonic development over the past decades. However, interpretation of the phenotype of mutant mice is potentially complicated, since the commonly used knockout approach modifies both the fetal and placental genome. To circumvent this problem, we previously developed a placenta‐specific gene manipulation system by lentiviral vector transduction of embryos at the blastocyst stage. In the present study, by combination with the Cre/ LoxP system, we successfully demonstrate placenta‐specific gene activation and inactivation in EGFP reporter mice and Ets2 floxed mice, respectively. Transient expression using integrase‐defective lentiviral (IDLV) vectors diminished the toxic effect of Cre expression and solved the dilemma of mosaic recombination with lower concentrations and toxic effects with higher concentrations of Cre recombinase. We also show that placenta‐specific Ets2 disruption causes embryonic lethality and reconfirmed the critical role of Ets2 during placentation. This technology facilitates both gain and loss of gene function analyses in placental development during pregnancy. Since IDLV vectors can efficiently transduce a variety of cell types similarly to wild‐type vectors, our IDLV‐Cre strategy is potentially useful for a wide range of applications. genesis 47:793–798, 2009. © 2009 Wiley‐Liss, Inc.